Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pasithea Therapeutics Corp. Warrant (KTTAW:NASDAQ), powered by AI.
Pasithea Therapeutics Corp. Warrant is currently trading at $0.01. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Pasithea Therapeutics Corp. Warrant on Alpha Lenz.
View Pasithea Therapeutics Corp. Warrant's valuation metrics on Alpha Lenz.
“Pasithea Therapeutics Corp. Warrant's ROE is -58.4%. Explore profitability and growth together.”
Ask for details →Pasithea Therapeutics Corp. Warrant represents a unique financial instrument associated with Pasithea Therapeutics, a company engaged in advancing scientific research and development in the healthcare and pharmaceutical sectors. Warrants provide holders the right, but not the obligation, to purchase shares of Pasithea Therapeutics at a predetermined price before the expiration date. This asset allows investors to potentially leverage their exposure to the company's future growth prospects without initially committing large capital outlays required for buying stock outright. The key feature of this warrant is its potential to provide amplified returns if Pasithea Therapeutics' stock appreciates, attracting investors interested in innovative treatments for mental health therapies. Operating in the dynamic biopharmaceutical industry, the issuance of such warrants helps Pasithea Therapeutics raise capital while offering investors a speculative tool to participate in the volatile biotech market. Warrants like these play a vital role in a company's capital strategy, providing access to funds that support ongoing research and development efforts.
“Pasithea Therapeutics Corp. Warrant's ROE is -58.4%. Explore profitability and growth together.”
Ask for details →Pasithea Therapeutics Corp. Warrant (ticker: KTTAW) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 4 employees.
The current price is $0.011 with a P/E ratio of -x and P/B of -x.
ROE is -58.36%.